NCT03760640View on ClinicalTrials.gov

A Study of LY900014 in a Medtronic Pump

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 18, 2019

Primary Completion Date

October 7, 2019

Study Completion Date

October 7, 2019

Conditions
Type1 Diabetes Mellitus
Interventions
DRUG

LY900014

Administered SC

DRUG

Insulin Lispro

Administered SC

Trial Locations (2)

30318

Atlanta Diabetes Associates, Atlanta

55416

International Diabetes Center, Saint Louis Park

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03760640 - A Study of LY900014 in a Medtronic Pump | Biotech Hunter | Biotech Hunter